Caption Management’s Wave Life Sciences WVE Stock Holding History

Caption Management’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-160,000	Closed	-$1.16M	–	2116
2026 Q1	$1.16M	Buy	160,000 +140,800	+733%	+$1.83M	0.01%	979
2025 Q4	$326K	Buy	+19,200	New	+$195K	﹤0.01%	1316
2025 Q2	–	Sell	-25,000	Closed	-$202K	–	1961
2025 Q1	$202K	Sell	25,000 -100,000	-80%	-$1.09M	﹤0.01%	1269
2024 Q4	$1.55M	Buy	+125,000	New	+$1.67M	0.01%	787
2021 Q2	–	Sell	-126,600	Closed	-$711K	–	1612
2021 Q1	$711K	Buy	+126,600	New	+$1.22M	0.02%	741
2020 Q1	–	Sell	-36,000	Closed	-$289K	–	1113
2019 Q4	$289K	Buy	36,000 +16,000	+80%	+$392K	0.01%	692
2019 Q3	$411K	Hold	20,000	–	–	0.02%	512
2019 Q2	$522K	Buy	+20,000	New	+$561K	0.03%	471

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

GSK plc London $602M AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RAM

Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Caption Management's WVE Position: Q2 2026 in Review

Caption Management reduced its Wave Life Sciences (WVE) stake by 79% in Q2 2026, selling an estimated $227K and leaving 9,000 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Caption Management first reported a position in WVE in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.1M in Q2 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Caption Management held 9,000 shares of Wave Life Sciences worth $52.3K as of Q2 2026.
Caption Management sold 34,200 Wave Life Sciences shares in Q2 2026, an estimated $227K.
Wave Life Sciences made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1548 holding.
Caption Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 9 quarters since.
Caption Management's Wave Life Sciences position peaked at $2.1M in Q2 2019.
239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.